| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |